Bordet


Also found in: Dictionary, Encyclopedia.

Bor·det

(bōr-dā'),
Jules, Belgian bacteriologist and Nobel laureate, 1870-1961. See: Bordetella, Bordet-Gengou potato blood agar, Bordet-Gengou bacillus, Bordet-Gengou phenomenon, Bordet and Gengou reaction.
References in periodicals archive ?
Auteur responsable pour la correspondance : Dr Camilo Garcia, Departement de Medecine Nucleaire, Institut Jules Bordet, Universite Libre de Bruxelles (ULB), Rue Heger-Bordet, 1, B-1000 Brussels, Belgium, Tel.
Lacroix is affiliated with the Institut Jules Bordet, Belgium
Consultant Anaesthesiologist, Department of Anaesthesiology, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
With the aid of genetics we are able to identify specific patients who will respond to certain regimens, while avoiding detrimental side effects for the remainder of patients, who are unlikely to benefit, according to conference co-chair and study author Professor Martine Piccart of the Institut Jules Bordet in Brussels.
The BIG 2-98 trial, presented by Dr De Azambuja of the Jules Bordet Institute in Brussels has shown that women with a BMI over 30 had poorer outcomes for disease-free survival and overall survival.
of the Jules Bordet Institute, Brussels, reported that only the 1-year arm was unblinded early.
174; cited in Ponnelle and Bordet, 414; Cisrellini, 1:757; and Barbieri et al.
Bordet, in 1898, was one of the first researchers to discover one of the properties of antiserum: that when the antiserum raised against an animal was added to the serum of that animal, 'the latter first became opaque, and that after a short time a flocculent precipitate fell' (Nuttall 1901a: 788).
Martine Piccart-Gebhart who is a Professor of Oncology at the Universite Libre de Bruxelles and Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium.
Ahmed Awada, Professor and Head of the Medical Oncology Clinic, Jules Bordet Institute, Brussels & Free Universities, Brussels, Belgium
a Fellow at the Department of Medical Oncology at the Institute Jules Bordet (Brussels, Belgium), and colleagues in Italy analysed results from 14 trials that had taken place between 1970 and 2009, involving 1,417 pregnant women with a history of breast cancer and 18,059 women with a history of breast cancer who were not pregnant.